Analysis
| Earnings estimate |
Current quarter (Oct 2025) |
Next quarter (Jan 2026) |
Current year (Jan 2026) |
Next year (Jan 2027) |
|---|---|---|---|---|
| Number of analysts | 38 | 37 | 49 | 52 |
| Average estimate | 1.24 | 1.42 | 4.50 | 6.37 |
| Low estimate | 1.14 | 1.24 | 4.14 | 4.91 |
| High estimate | 1.34 | 1.81 | 5 | 7.50 |
| Last year EPS | 0.81 | 0.89 | 2.99 | 4.50 |
| Revenue estimate |
Current quarter (Oct 2025) |
Next quarter (Jan 2026) |
Current year (Jan 2026) |
Next year (Jan 2027) |
|---|---|---|---|---|
| Number of Analysts | 39 | 38 | 55 | 60 |
| Avg. estimate | 54.65B | 61.14B | 206.46B | 275.14B |
| Low estimate | 53.46B | 56.53B | 193.52B | 226.15B |
| High estimate | 58.34B | 75.31B | 224.96B | 325.98B |
| Last year sales | 35.08B | 39.33B | 130.50B | 206.46B |
| Sales growth | 0.56 | 0.55 | 0.58 | 0.33 |
| EPS trend |
Current quarter (Oct 2025) |
Next quarter (Jan 2026) |
Current year (Jan 2026) |
Next year (Jan 2027) |
|---|---|---|---|---|
| Current estimate | 1.24 | 1.42 | 4.50 | 6.37 |
| 7 days ago | 1.24 | 1.41 | 4.50 | 6.35 |
| 30 days ago | 1.24 | 1.41 | 4.49 | 6.31 |
| 60 days ago | 1.18 | 1.35 | 4.30 | 5.86 |
| 90 days ago | 1.17 | 1.33 | 4.28 | 5.74 |
| EPS revisions |
Current quarter (Oct 2025) |
Next quarter (Jan 2026) |
Current year (Jan 2026) |
Next year (Jan 2027) |
|---|---|---|---|---|
| Up last 7 days | 0 | 1 | 1 | 2 |
| Up last 30 days | 29 | 5 | 7 | 40 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 6 | 1 | 1 | 3 |
| Growth estimates | |
|---|---|
| Current qtr (Oct 2025) | 0.535% |
| Next qtr. (Jan 2026) | 0.590% |
| Current year (2025) | 0.506% |
| Next 5 years (per annum) | 0.611% |
| Past 5 years (per annum) | 0.838% |